
Decades of research and collaborations have transformed the outlook for cancers affecting children (ages 0 to 14) and adolescents (ages 15 to 19), collectively referred to as the pediatric cancers in this report.
Enormous progress has been made in the treatment of pediatric cancers over the past several decades, as reflected in the greater than 85 percent 5-year relative survival rates for all cancers combined.
Learn MoreEvidence-based frameworks for survivorship care, including the Children’s Oncology Group Long-Term Follow-Up Guidelines, are essential to monitoring, preventing, and managing late effects across the lifespan.
Learn MoreSurvival rates for patients with pediatric cancers have improved dramatically in recent decades thanks to research-driven advances.
Learn More



